Company: TELO
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-023970
Chunk: 39

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 8
Chunk 39
---
840,000 based on the stock quoted trading
price at the grant date and were expensed immediately as compensation expense.

Warrants

In
connection with various transactions and the IPO summarized below, the Company issued stock warrants. Warrant activity for the three
months ended June 30, 2025 and 2024 is summarized below:

 Schedule
of warrant activity

    Weighted  

    Weighted  
    Average  

    Number of  
    Average Exercise  
    Remaining Contractual  
    Aggregate Intrinsic 

    Warrants  
    Price  
    Term (Years)  
    Value 
  
    Outstanding as December 31, 2023 
     2,774,057  
    $4.85  
     4.5 (1) 
     - 
  
    Granted 
     50,000  
    $7.0  
     4.1  
     - 
  
    Outstanding as June 30, 2024 
     2,824,057  
    $4.89  
     4.49  
     - 

    Outstanding as December 31, 2024 
     2,814,057  
    $4.97  
     3.49 (2) 
     - 
  
    Granted 
     -  
    $-  
     -  
     - 
  
    Outstanding as June 30, 2025 
     2,814,057  
    $4.97  
     3.0 (2) 
     - 
  
    Exercisable, June 30, 2025 
     2,814,057  
    $4.97  
     3.0 (2) 
     - 

    1)
     
    The
    warrants herein consist of various contractual terms. The warrants herein consist of 2,429,025 warrants issued to Bay Shore Trust
    that have a remaining contractual term of 4.5 years as of December 31, 2023, and 335,032 warrants issued to investors associated
    with the 2023 Private Placement that currently have an indeterminable contractual term. See disclosures below for more information
    on these warrants.

    (2)
     
    The
    warrants herein consist of various contractual terms. The